ABOUT CRIDO

CRIDO has advised Amplifon on a transaction in the medical products industry

4 November 2022
2 min

CRIDO's interdisciplinary team of experts has advised Amplifon on the acquisition of 100% of the shares of a medical products entity. This is another step in building Amplifon's market advantage, which offers personalized and innovative hearing-related products and services.

Operating in the medical products industry, Amplifon has expanded its portfolio in Poland by purchasing 100% of the shares of an entity offering services in the same sector. CRIDO's team was responsible for the legal and tax aspects of the transaction on the buyer's side.

As CRIDO, we support companies wanting to expand their business – i.a. through M&A transactions. The Amplifon transaction is yet another consolidation project in which we were able to advise the buyer’s side, and which leads to our client gaining a greater advantage and market share. We are delighted that clients entrust us with the execution of such transactions and that we can add our contribution to the development of their business. -  says Przemysław Furmaga, Partner responsible for legal advisory in the M&A team at CRIDO.

Przemysław Furmaga, Partner responsible for legal advisory in the M&A team at CRIDO, Michal Klimowicz, Senior Associate at CRIDO, and Filip Sobociński, Junior Associate at CRIDO, were responsible for the legal aspects of the transaction, including legal due diligence and preparation of transaction documentation. On the tax side, the buyer was advised by Mateusz Stańczyk, Partner responsible for tax advisory in the M&A team at CRIDO, Tomasz Koterbski, Manager at CRIDO, and Maciej Rosiński, Senior Consultant at CRIDO.

CRIDO's M&A team supports clients in all or selected areas of the transaction process: corporate finance, due diligence (financial, tax, legal), development of transaction structures, preparation of transaction documentation, as well as legal and tax advice at each stage of the transaction.